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Phenolic compounds form one of the main classes of secondary metabolites. They display a 
large range of structures and are responsible for the major organoleptic characteristics of 
plant-derived foods and beverages, particularly color and taste properties. They also 
contribute to the nutritional qualities of fruits and vegetables. Among these compounds, 
flavonoids constitute one of the most ubiquitous groups of plant phenolics. Owing to their 
importance in food organoleptic properties and human health, a better understanding of their 
structures and biological activities indicates their potentials as therapeutic agents and also for 
predicting and controlling food quality. Due to the variety of pharmacological activities in the 
mammalian body, flavonoids are more correctly referred as “nutraceuticals”.   
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INTRODUCTION 
Phenolic compounds constitute one of the 
main classes of secondary metabolites. They 
display a large range of structures and they 
are responsible for the major organoleptic 
characteristics of plant-derived foods and 
beverages, particularly color and taste 
properties and they also contribute to the 
nutritional qualities of fruits and vegetables. 
The most important natural pigments are 
carotenoids which are tetrapyrrole derivatives 
of naturally occurring phenolic compounds 
ubiquitously distributed in plant kingdom. 
Among these compounds, flavonoids 
constitute one of the most ubiquitous groups 
of all plant phenolics. So far, over 8,000 
varieties of flavonoids have been identified
1
. 
Until ~50 years ago, information on the 
working mechanisms of flavonoids was scare. 
But it has been widely known for centuries 
that compounds of plant origin possess a 
broad spectrum of biological activity
2
. In 1930, 
Szent-Gyorgyi isolated a new substance from 
oranges and classified it as vitamin P but 
later, it became clear that this substance was 
actually a flavonoid
3
. Flavonoids drew greater 
attention from researchers with the discovery 
of the French Paradox, i.e., the decrease 
incidence of cadio-vascular disease observed 
in the Mediterranean population which was 
associated with red wine consumption, and a 
greater amount of saturated fat the average 




STRUCTURE AND CLASSIFICATION OF 
FLAVONOIDS 
Flavonoids occur as aglycones, glycosides 
and methylated derivatives
4
. In plants, 
flavonoids aglycones (i.e., flavonoids without 
attached sugar) occur in a variety of structural 
forms. All contain fifteen carbon atoms in their 
basic nucleus: two six-membered rings linked 
with a three carbon unit which may or may not 
be a part of a third ring
5
. For convenience, the 
rings are labeled A, B, and C (see Fig 1). The 
individual carbon atoms are based on a 
numbering system which uses ordinary 
numerals for the A and C and “primed” 
numerals for B-ring (1). Primed modified 
numbering system is not used for chalcones 
(2) and the isoflavones derivatives (6): the 
pterocarpans and the rotenoids
6
. The different 
ways to close this ring associated with the 
different oxidation degrees of ring A provide 
the various classes of flavonoids. 
The six-membered ring condensed with the 
benzene ring is either a γ-pyrone (flavones (1) 
flavonols (3)) or its dihydroderivative (flavanones 
(4) and flavan-3-ols (5)). The position of the 
benzenoid substituent divides the flavonoids into 
two classes: flavonoids (1) (2-position) and 
isoflavonoids (6) (3-position). Most flavonoids occur 
naturally associated with sugar in conjugated form 
and, within any one class, may be characterized as 
monoglycosidic, diglycosidic, etc. The glycosidic 
linkage is normally located at position 3 or 7 and 
the carbohydrate unit can be L-rhamnose, D-




FLAVONOIDS AS NUTRACEUTICAL 
“Nutraceutical” is a term coined in 1979 by 
Stephen DeFelice
9
. It is defined “as a food or 
parts of food that provide medical or health 
benefits, including the prevention and 
treatment of disease.” Nutraceuticals may 
range from isolated nutrients, dietary 
supplements, and diets to genetically 
engineered “designer” food, herbal products, 
and processed products such as cereals, 
soups, and beverages. A nutraceutical is any 
nontoxic food extract supplement that has 
scientifically proven health benefits for both 
the treatment and prevention of disease
10
. 
The increasing interest in nutraceuticals 
reflects the fact that consumers hear about 
epidemiological studies indicating that a 
specific diet or component of the diet is 
associated with a lower risk for a certain 
disease. 
The major active nutraceutical ingredients in 
plants are flavonoids. As is typical for phenolic 
compounds, they can act as potent 
antioxidants and metal chelators. They also 
have long been recognized to possess anti-
inflammatory, antiallergic, hepatoprotective, 
antithrombotic, antiviral, and anticarcinogenic 
activities, as discussed in the subsections that 
follow:  
Antioxidant activity 
The best-described property of almost every 
group of flavonoids is their capacity to acts as 
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antioxidants. The flavones and catechins 
seem to be the most powerful flavonoids for 
protecting the body against reactive oxygen 
species (ROS). Body cells and tissues are 
continuously threatened by the damage 
caused by free radicals and ROS which are 
produced during normal oxygen metabolism 
or are induced by exogeneous damage
11,12
. 
Free radicals and ROS have been implicated 
in a large number of human diseases
13,14
. 
Quercetin, kaempferol, morin, myricetin and 
rutin, by acting as antioxidants, exhibited 
beneficial effects such as anti-inflammatory, 
antiallergic, antiviral, as well as anticancer 
activity. They have also been suggested to 
play a protective role in liver diseases, 
cataracts, and cardiovascular diseases. 
Quercetin and silybin, acting as free radical 
scavengers, were shown to exert a protective 
effect in liver reperfusion ischemic tissue 
damage
15,16
. The scavenging activity of 
flavonoids has been reported to be in the 
order: Myrcetin > quercetin > rhamnetin > 
morin > diosmetin > naringenin > apigenin > 
catechin > 5,7-dihydroxy-3’,4’,5’-trimethoxy-




Flavonoids and esters of phenolic acids have 
also been investigated for their antibacterial, 
antifungal and antiviral activities. 
Antibacterial activity 
Antibacterial activity has been displayed by a 
number of flavonoids. Quercetin has been 
reported to completely inhibit the growth of 
Staphylococcus aureus. Most of the 
flavonones having no sugar moiety showed 
antimicrobial activities whereas none of the 
flavonols and flavonolignans tested showed 




A number of flavonoids isolated from the 
peelings of tangerine orange, when tested for 
fungistatic activity towards Deuterophoma 
tracheiphila were found to be active; nobiletin 
and langeritin exhibited strong and weak 
activities, respectively, while hesperidin could 






































































Fig.1: Chemical structures of some representative flavonoids  
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Fig. 2: General structures for various classes of flavonoids 
 
 
Table 1: Substitution patterns of series of flavonoids 
 
Group 3 5 6 7 8 3’ 4’ 5’ C2=C3 
Flavones  
Apigenin H OH H OH H H OH H + 
Diosmin H OH H Oru H OH OH H + 
Luteolin H OH H OH H OH OH H + 
          
Flavonol  
Quercetin OH OH H OH H OH OH H + 
Kaempferol OH OH H OH H H OH H + 
Galangin OH OH H OH H H H H + 
Fisetin OH H H OH H OH OH H + 
Myricetin OH OH H OH H OH OH OH + 
Vitexicarpin OCH3 OH OCH OCH3 H OH OCH3 H + 
          
Flavanone  
Naringenin H OH H OH H H OH H - 
Eriodictyol H OH OH OH H OH OH H - 
Pinocembrin H OH H OH H H H H - 
Liquiritigenin H H H OH H H OH H - 
          
Flavanonol  
Taxifolin H OH H OH H OH OH H - 
          
Isoflavone  
Genistein - OH H OH H H OH H + 
Tectorigenin - OH OCH3 OH H H OH H + 
Daidzein - H H OH H H OH H + 
Formononetin - H H OH H H OCH3 H + 
          
Flavan-3-ols  
(+) Catechin βOH OH H OH H OH OH H - 
(-) Epicatechin αOH OH H OH H OH OH H - 
(-) Epigallocatechin αOH OH H OH H OH OH OH - 
          
Flavylium Salts  
Cyanidin OH OH H OH H OH OH H - 
Pelargonidine OH OH H OH H H OH H - 
 
was the first chlorine-containing flavonoid-type 





Naturally occurring flavonoids with antiviral 
activity have been recognized since the 1940s 
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but only recently have attempts been made to 
make synthetic modifications of natural 
compounds to improve antiviral activity. 
Quercetin, morin, rutin, dihydroquercetin 
(taxifolin), apigenin, catechin, and hesperidine 
have been reported to possess antiviral 
activity against some of the 11 types of 
viruses
25
. The antiviral activity appears to be 
associated with the nonglycosidic compounds, 
and hydroxylation at the 3-position is 
apparently a prerequisite for antiviral activity. 
It has been found that flavonols are more 
active than flavones against Herpes simplex 
virus type 1 and the order of importance was 
galangin>kaempferol>quercetin
26
. Recently, a 
natural plant flavonoid polymer of molecular 
weight 2,100 daltons was found to have 
antiviral activity against two strains of type 1 
Herpes simplex virus and type 2 Herpes 
simplex viruses
27
. Because of the worldwide 
spread of HIV since the 1980s, the 
investigation of the antiviral activity of 
flavonoids has mainly focused on HIV
28
. There 
have appeared several recent reports on the 
anti-AIDS activity of flavonoids. Out of twenty 
eight flavonoids tested, the flavans were 
generally more effective than flavones and 
flavonones in the selective inhibition of HIV-1 
and HIV-2 or similar immunodeficiency virus 
infections
29
.       
Effect on gastrointestinal system 
Antiulcer activity 
Some recent studies have indicated that 
flavonoids possess antiulcerogenic activity. 
Flavonoid glycosides of Ocimum basilicum 
(Labiatae) decreased ulcer index, and 
inhibited gastric acid and pepsin secretions in 
aspirin-induced ulcers in rats
30
. Quercetin, 
rutin, and kaempferol administered 
intraperitoneally (25-100 mg/kg) inhibited 
dose-dependent gastric damage produced by 




The liver is subject to acute and potentially 
lethal injury by several substances including 
phalloidin (the toxic constituent of the 
mushroom, Amanita phalloides), CCl4, 
galactosamine, ethanol, and other 
compounds. Flavonoids have also been found 
to possess hepatoprotective activity. In a 
study carried out to investigate the flavonoid 
derivatives silymarin, apigenin, quercetin, and 
naringenin, as putative therapeutic agents 
against microcrystin LR-induced 
hepatotoxicity, silymarin was found to be the 
most effective one
32
. The flavonoid, rutin and 
venoruton, showed regenerative and 





The anti-inflammatory activity of flavonoids in 
many animal models have been reported. 
Flavone/flavonol glycosides as well as 
flavonoid aglycons have been reported to  
exert significant anti-inflammatory activity in 
the animal model of both acute and chronic 
inflammation when given orally or 
topically
34,35
. Hesperidin, a citrus flavonoid, 
possesses significant anti-inflammatory and 
analgesic effects
36
. Recently apigenin, luteolin 




A number of reports have been published 
which demonstrate that flavonoids can 
modulate arachidonic acid metabolism via the 
inhibition of cyclo-oxygenase (COX) and 
lipooxygenase activity (LO). Also, it has been 
speculated that the anti-inflammatory and anti-
allergic properties of flavonoids are the 




flavones/flavonols kaempferol, quercetin, 
myricetin, fisetin were reported to possess LO 




Flavonoids, especially quercetin, has been 
reported to possess antidiabetic activity. 
Vessal et al reported that quercetin brings 
about the regeneration of pancreatic islets and 
proprably increases insulin release in 
strptozotocin-induced diabetic rats
41
. Also in 
another study, Hif and Howell reported that 
quercetin stimulate insulin release and 
enhanced Ca
2+
 uptake from isolated islets cell 
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O2   (Superoxide anion) 
 
One-electron reduction product of O2. Produced by phagocytes, formed 
in autoxidation reactions (flavoproteins, redox cycling), and generated 




Potonated form of O2. “-“ 
 
H2O2 (Hydrogen Peroxide) 
 
Two-electron reduction product of O2 formed from O2 by ”-“ dismutation 
or directly from O2. Reactivity of O2 and H2O2 is amplified in the 
presence of heme proteins. 
 
OH (Hydroxy radical)  
 
Three-electrons reduction product of O2 generated by Fenton reaction, 
transition metal (iron, copper)-catalysed Haber-Weiss reaction; also 
formed by decomposition of peroxynitrite produced by the reaction of O2 
with NO
.




 (Alkoxy radical) 





 (Peroxyl radical) Example: Lipid peroxy radical (LOO
.
) produced from organic 
hydroperoxide (e.g. lipid hydroperoxide, LOOH), ROOH by hydrogen 
abstraction. 
1
O2 Singlet oxygen 
 
 


















Effect on cardiovascular system 
Vasorelaxant agent 
The consumption of flavonoids may prevent 
endothelial dysfunction by enhancing the 
vasorelaxant process leading to a reduction of 
arterial pressure
44,45
. Endothelial dysfunction 
represents a critical event in the development 
of cardiovascular diseases and the major 




The consumption of flavonoids can prevent a 
number of cardiovascular diseases including 
._ ._ 
• The catechol (O-dihydroxy) group in the ring confers great scavenging ability. 
• A pyrogallol (trihydroxy) group in ring B of a catechol, as in myricetin, produces even 
higher activity. The C2-C3 double bond of the C ring appears to increase scavenger 
activity because it confers stability to the phenoxy radical produced. 
• The 4-oxo (keto double bond at position 4 of the C ring), especially in association with 
the C2-C3 double bond, increases scavenger activity by delocalizing electrons from B-
ring. 
• The 3-OH group on the C ring generates an extremely active scavenger; in fact, the 
combination of C2-C3 double bond and 4-oxo group appears to be the best combination 
on the top of the catechol group. 
• The 5-OH and 7-OH groups may also add scavenging potential in certain cases.  
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Recently, many experimental studies have 
shown that these polyphenolic compounds 
may reduce the arterial pressure in rats and 
enhance the vasorelaxant process. The 
endothelium-dependent relaxation induced by 
flavonoids has been well documented. 
Furthermore, Also investigators have 
demonstrated that Anthocyanin delphinidin 





Oxidative modification of low-density 
lipoproteins (LDL) by free radicals is an early 
event in the pathogenesis of atherosclerosis. 
The rapid uptake of oxidatively-modified LDL 
via a scavenger receptor leads to the 
formation of foam cells. Flavonoids may 
directly scavenge some radical species by 
acting as a chain braking antioxidant
51
. The 
ability of quercetin and the quercetin 
glycosides to protect LDL against oxidative 
modification has shown a significant protective 
effect
52
. Furthermore, a Japanese study 
reported an inverse correlation between 





Platelet aggregation plays a pivotal role in the 








7-monohydroxyehtylrutoside (34)  
 




Fig. 4: Links indicating effects of flavonoids on different diseases 
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platelets adhering to vascular endothelium 
generate lipid peroxides and oxygen free 
radicals which inhibit the endothelial formation 
of prostacyclin and nitrous oxide. It was 
shown in the 1960s that tea pigment can 
reduce blood coagulability, increase 
fibrinolysis, and prevent platlet adhesion and 
aggregation
54
. Selected flavonoids such 
quercetin, kaempferol and myricetin were 
shown to be effective inhibitors of platelet 
aggregation in dogs and monkeys
55
. Flavonols 
are particularly antithrombotic because they 
directly scavenge free radicals, thereby 
maintaining proper concentration of 
endothelial prostacyclin and nitric oxide
56
. One 
study showed that flavonoids are powerful 
antithrombotic agents in vitro and in vivo 
because of their inhibition of the activity of 
cyclooxegenase and lipoxigenase pathways
57
.    
Cardioprotective effects 
Recent interest in flavonoids has been 
stimulated by the potential health benefits 
arising from the antioxidant activity of these 
ployphenolic compounds. These are the result 
of their high propensity to transfer electrons, 
chelate ferrous ions, and scavenge reactive 
oxygen species
58
. Because of these 
properties, flavonoids have been considered 
as potential protectors against chronic 
cardiotoxicity caused by the cytostatic drug 
doxorubicin. Doxorubicin is a very effective 
antitumor agent but its clinical use is limited by 
the occurrence of a cumulative dose-related 
cardiotoxicity, resulting in, for example, 
congestive heart failure (negative inotropic 
effect). In a recent report, the cardiotoxicity of 
doxorubicin on the mouse left atrium has been 






A sufficient number of flavonoids have 
exhibited antineoplastic activity. Several 
recent reviews have highlighted this activity. 
Detailed studies
62-64
 have revealed that 
quercetin exerted a dose-dependent inhibition 
of growth and colony formation. The 
flavonoids, kaempferol, catechin, toxifolin and 
fisetin, also suppressed cell growth
65, 66
. On 
screening the antileukaemic efficacy of 28 
naturally occurring and synthetic flavonoids on 
human promyelocytic leukaemic HL-60 cells, 




Effect on central nervous system 
Synthetic flavonoids, such as 6-bromoflavone 
and 6-bromo-3’-nitroflavones, were shown to 
displace [3H] flumazenil binding to 
membranes from rat cerebellum but not from 
spinal cord, indicating selectivity for the BZ-
Omega receptor subtype, but the latter was 
more potent than 6-bromoflavone. Results 
from two conflict tests in rats showed that 
these synthetic flavonoids possess anxiolytic-




Toxicity of flavonoids 
Flavonoids are ubiquitous in plant foods and 
drinks and, therefore, a significant quantity is 
consumed in our daily diet. The toxicity of 
flavonoids is very low in animals. For rats, the 
LD50 is 2-10 g per animal for most flavonoids. 
Similar doses in humans are quite unrealistic. 
As a precaution, doses less than 1mg per 
adult per day have been recommended for 
humans
70
. Dunnick and Hailey reported that 
high doses of quercetin over several years 
might result in the formation of tumors in 
mice
71
. However, in other long-term studies, 
no carcinogenicity was found
72
. Moreover, as 
described earlier, quercetin has been reported 
to be anti-mutagenic in vivo. 
 
CONCLUDING REMARKS 
Flavonoids comprise a vast array of 
biologically active compounds that are 
ubiquitous in plants, many of which have been 
used in traditional eastern medicine for 
thousands of years. They also constitute an 
unavoidable components of the diet. In the 
present review, we have reviewed detailed 
structural aspects and biological properties of 
flavonoids. The chemical and structural 
similarities of flavonoids with numerous 
biomolecules as well as their crucial role in 
plant-insect and plant-bacterial interactions 
make them an attractive class of 
phytoconstituents for biological activity. Their 
Tapas et al 
Trop J Pharm Res September 2008; 7 (3) 1097 
widespread occurrence, broad spectrum 
diversity and natural origin make them 
appropriate chemical scaffolds for novel 
therapeutic agents. Of the many actions of 
flavonoids, antioxidant and antiproliferative 
effects stand out. Given that certain 
substituents are known to be required or 
increase their actions, the therapeutic 
potential of selected flavonoids is fairly 
obvious. These natural compounds have 
several great advantages over other 
therapeutic agents for the following reasons:  
i) Many diets are rich in these phenolics and 
are daily consumed.  
ii) They rarely have any side effects.  
iii) They have relatively long half-life  
iv) They can be easily absorbed in the 
intestine after ingestion.  
The study of flavonoids is complex because of 
the heterogeneity of different molecular 
structures and the scarcity of data on 
bioavailability. There is a need to improve 
analytic techniques to allow collection of more 
data on absorption and excretion. Data on the 
long-term consequences of chronic flavonoid 
ingestion are especially scarce. Finally, we 
think that natural, hemisynthetic and synthetic 
flavonoids alone or in combination with other 
preventive and/or therapeutic strategies will 
become effective future drugs against the 
most common degenerative diseases such as 
cancer, diabetes and cardiovascular 
complications.            
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